ASX-listed EBOS Group set for best day in 9 years on strong annual results

EBOS

19/08/2026 05:38

** ASX-listed shares of EBOS Group EBO.AX rise as much as 13.4% to A$20.67, highest level since February 27
** On track to log its best session since September, 2017
** The pharmaceutical company posts annual revenue of NZ$13.5 billion ($7.93 billion), up 9.9%
** Reports statutory net profit after tax of NZ$225.2 million, up 4.7%
** Attributes rise to broad-based growth across Healthcare and Animal Care segments, along with contributions from recent acquisitions
** About 225,000 shares change hands, 2.2 times the 30-day avg
** EBO down 17% YTD, including the session's moves
     
     
($1 = 1.7033 New Zealand dollars)

 (Reporting by Anjali Singh in Bengaluru)
 ((anjali.singh2@thomsonreuters.com;))